The Serum Institute of India will launch children vaccine Covavax in six months, said its CEO on Tuesday during an event organised by the Confederation of Indian Industries (CII).
â€œCurrently Covavax for kids aged three and above is under trialâ€ he added.
Covavax is the version of US-based Novavaxâ€™s Covid vaccine candidate.
â€œThere is enough data to show that the vaccines will work and protect children against the virus. Donâ€™t know what will happen with Omicron. So far children have not been affected very badly,â€ said Poonawala.
â€œYes, you should go and get your children vaccinated. There is no harm. These vaccines are safe and efficacious,â€ he further added.
The Pune-based firm had submitted interim safety and immunogenicity data of phase 2/3 bridging clinical trials conducted in the country as well as interim clinical trial data of safety and efficacy from phase 3 clinical trials conducted in the UK and the US along with its application.
Till now India has approved only one Covid vaccine, Zydus Healthcareâ€™s ZyCoV-D, for children aged 12 years, for emergency use. Besides this, Bharat Biotechâ€™s Covaxin is yet to be approved by the Drug Controller General of India for emergency use in India.